Latest News

NXP Semiconductors (NXPI) just wrapped up FY 2025 with Q4 revenue of US$3.3b and basic EPS of US$1.80, anchored by net income of US$455m, setting the stage for how investors read the year as a whole. The company has seen quarterly revenue move from US$3.1b in Q4 2024 to US$3.3b in Q4 2025, alongside quarterly EPS shifting from US$1.95 to US$1.80, which feeds into trailing twelve month EPS of US$8.00 on revenue of US$12.3b. With trailing net income of US$2.0b and a reported net margin that has...

Ascletis Pharma recently filed a follow-on equity offering of HK$843.54 million via a subsequent direct listing, issuing 69,256,000 ordinary shares at HK$12.18 each. The fundraising follows positive Phase III data for denifanstat in moderate-to-severe acne and progress with ASC30 in metabolic disease, underscoring Ascletis’s late-stage pipeline momentum. We’ll now explore how this combination of positive Phase III acne data and a sizable equity raise shapes Ascletis Pharma’s investment...

Healthpeak Properties (NYSE:DOC) is planning an IPO of Janus Living to spin off its senior housing assets. The company has announced a $1b capital recycling program to reshape its real estate portfolio. Healthpeak also hired a former Palantir executive as Head of Enterprise Innovation to focus on technology and data driven operations. Healthpeak Properties, trading at $16.45, is reshaping its portfolio around core healthcare real estate while separating senior housing into the new Janus...

Analysts recently highlighted Vericel as a Growth at a Reasonable Price candidate, citing strong momentum in its earnings and revenue forecasts alongside a debt-free balance sheet and solid profitability metrics. This combination of projected earnings expansion, revenue growth and financial strength positions Vericel as a case study in how growth-focused investors may view profitable, balance-sheet-light businesses. With robust earnings growth projections at the center of the story, we’ll...

CapitaLand Investment Limited has announced a distribution of S$0.039 per unit for the period from 1 July 2025 to 31 December 2025, with the ex-distribution date on 12 February 2026, record date on 13 February 2026, and payment scheduled for 19 March 2026. This latest distribution decision highlights CapitaLand Investment’s continued emphasis on cash returns to unitholders, with clear timelines that may help income-focused investors plan their portfolios. Next, we’ll explore how this higher...

If you are wondering whether Kyivstar Group's current share price reflects its true worth, you are not alone. This article focuses squarely on that question. The stock recently closed at US$11.83, with a 7 day return of 6.0% decline, a 30 day return of 10.9% decline, and a 1 year return of 14.4%, which points to shifting expectations and risk perceptions over different time frames. Recent news coverage around Kyivstar Group has focused on its position as a US listed telecom player with...

Genesis Minerals (ASX:GMD) has shaken up its leadership, shifting Raleigh Finlayson to Executive Chair and promoting Matthew Nixon to CEO, as the miner aims to align governance, growth plans and day-to-day operations. See our latest analysis for Genesis Minerals. The leadership reshuffle comes after a mixed short term run, with a 2.96% 1 day share price return and a 10.09% 7 day share price decline. This is set against a 24.32% 90 day share price return and a very large 5 year total...

Samsara (NYSE:IOT) is expanding its Canadian footprint with local data hosting, domestic logistics partnerships, and new AI safety features. The rollout focuses on data residency, regional hardware fulfillment, and support for customers operating in remote parts of Canada. The company is tailoring its connected operations platform to Canadian fleets and industrial operators that face strict compliance and connectivity requirements. Samsara runs a connected operations platform that links...

Objective (ASX:OCL) has drawn fresh attention after its board approved an on market buyback of up to 9,590,176 shares, or 10% of issued capital, running through to February 5, 2027. See our latest analysis for Objective. That buyback decision comes after a stretch of weaker momentum, with the share price at A$14.63 and a 90 day share price return showing a decline of 21.05%, while the 5 year total shareholder return of 13.72% remains in positive territory. If this kind of capital management...

If you are wondering whether Trane Technologies at around US$435 a share still offers reasonable value, you are not alone. This article is aimed at helping you frame that question clearly. The stock has posted returns of 11.0% over the last 7 days, 9.4% over the past month and year to date, and 23.6% over the past year, with a very large 3 year gain and a 219.1% return over 5 years that may be influencing how the market is thinking about future expectations and risk. Recent coverage has...

HAL Trust has announced an annual dividend of €3.50 per share, with an ex-dividend date of 14 May 2026, a record date of 15 May 2026, and payment scheduled for 21 May 2026. This dividend decision highlights how the trust is choosing to return capital to investors, which can influence perceptions of income stability and capital allocation. We will now explore how HAL Trust’s €3.50 per share annual dividend shapes its investment narrative, particularly for income-focused investors. We've found...

From what we can see, insiders were net buyers in Lindblad Expeditions Holdings, Inc.'s ( NASDAQ:LIND ) during the past...

Key Insights Using the Dividend Discount Model, National Grid fair value estimate is UK£12.16 National Grid's UK£12.56...

Sangamo Therapeutics recently reported detailed Phase 1/2 STAAR study results for its Fabry disease gene therapy, isaralgagene civaparvovec, and confirmed a rolling Biologics License Application submission to the FDA under the Accelerated Approval pathway, supported by kidney function as an intermediate clinical endpoint. The company paired these clinically promising data and regulatory progress with a roughly US$24.82 million follow-on equity raise and a finance leadership change,...

Keppel REIT (SGX:K71U) has reported FY 2025 first half revenue of S$197.7 million, with basic EPS of S$0.0196 and net income excluding extra items of S$76.0 million, setting the tone for its latest update to unitholders. Over the recent reporting periods, revenue has moved from S$180.0 million in 1H 2024 to S$191.5 million in 2H 2024 and then S$197.7 million in 1H 2025. Over the same periods, basic EPS shifted from S$0.0045 to S$0.0213 and then S$0.0196, giving investors a clearer view of how...

Labcorp Holdings (NYSE:LH) has amended its receivables purchase agreement, extending the facility’s termination date. The amendment adds an accordion feature that can increase borrowing capacity under certain conditions. The revised structure is intended to provide greater liquidity flexibility for the company’s operations and planning. Labcorp is a large diagnostics and laboratory services provider, so reliable access to funding is important for supporting day to day testing volumes and...

Why Central Bancompany is on investors’ radar today Central Bancompany (CBC) is drawing attention after a recent move in its share price, with the stock closing at $24.50 and showing varied returns over the past day, week, month, and past 3 months. See our latest analysis for Central Bancompany. While the 1 day share price return shows a 1.61% pullback to $24.50, the 90 day share price return of 15.29% sits alongside a 1 year total shareholder return of 89.00%. Together, these figures point...

If you are wondering whether WeRide's current share price offers value or just fresh risk, you are not alone. This article is going to focus squarely on what the numbers are saying about its valuation. WeRide's shares last closed at US$7.58, with returns of 14.3% decline over the past week, 19.3% decline over the past month, and 48.0% decline over the last year. This raises fair questions about how the market is currently pricing the stock. Recent news around autonomous driving regulation,...

ESR-LOGOS REIT (SGX:9A4U) opened FY 2025 with first half revenue of S$225.4 million and basic EPS of S$0.018, setting a fresh reference point after a volatile FY 2024. The trust has seen revenue move from S$182.9 million in 1H 2024 to S$190.5 million in 2H 2024 and then to S$225.4 million in 1H 2025. Basic EPS has shifted from a loss of S$0.030 in 1H 2024 to a loss of S$0.160 in 2H 2024, before landing in positive territory at S$0.018 in the latest half. This leaves investors focused on how...

If you are wondering whether Five9's current share price reflects its true worth, you are not alone. This article will walk through the key numbers that matter for valuation. Five9's share price closed at US$16.71, with returns of a 9% decline over 7 days, an 11.2% decline over 30 days, an 11.2% decline year to date, a 60.8% decline over 1 year, an 80.2% decline over 3 years and a 90.6% decline over 5 years, which naturally raises questions about both risk and potential. Recent coverage has...

If you are wondering whether UniFirst at around US$203 is a fair deal or a stretch, you are not alone. This article is built to help you frame that question clearly. The stock has seen mixed returns, with a 4.9% gain over the past month and year to date, against a 3.2% decline over the last 7 days and an 8% decline over the past year. These moves may have shifted how some investors view its potential and risks. Recent coverage around UniFirst has largely focused on the company as a long...

Alphabet recently moved to dramatically expand its footprint in India, securing rights to up to 2.4 million square feet of office space in Bengaluru that could house as many as 20,000 additional employees, while its Waymo unit raised US$16 billion at a US$126 billion valuation and investors looked ahead to Q4 2025 earnings. Together, the India build-out, Waymo funding, and Gemini- and cloud-focused expectations highlight how Alphabet is tying long-term AI and autonomous-mobility ambitions to...

Dr. Ing. h.c. F. Porsche (XTRA:P911) is in focus after reports that management is reassessing electric 718 Boxster and Cayman plans, while a new Head of Design arrives from McLaren in early 2026. See our latest analysis for Dr. Ing. h.c. F. Porsche. Those design changes and the rethink on electric 718 models are coming at a weaker moment for the stock, with a 1 month share price return of 16.39% and a 1 year total shareholder return of 30.16%, pointing to fading momentum after earlier...

If you are wondering whether Guardant Health at US$113.05 is starting to look expensive or still offers value, you are not alone in asking that question right now. The stock has seen a 1.3% decline over the last 7 days, an 11.1% return over the last 30 days and year to date, a 139.7% return over the last year, a 295.8% return over 3 years, and a 30.8% decline over 5 years. This may suggest the market’s view of its risk and potential has shifted over different time frames. Recent coverage has...